Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study
- PMID: 27526923
- PMCID: PMC4986258
- DOI: 10.1186/s12889-016-3366-5
Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study
Abstract
Background: The Human T Lymphotropic Virus type 1 (HTLV-1) subtype C is endemic to central Australia where each of the major sequelae of HTLV-1 infection has been documented in the socially disadvantaged Indigenous population. Nevertheless, available epidemiological information relating to HTLV-1c infection is very limited, risk factors for transmission are unknown and no coordinated program has been implemented to reduce transmission among Indigenous Australians. Identifying risk factors for HTLV-1 infection is essential to direct strategies that could control HTLV-1 transmission.
Methods: Risk factors for HTLV-1 infection were retrospectively determined for a cohort of Indigenous Australians who were tested for HTLV-1 at Alice Springs Hospital (ASH), 1st January 2000 to 30th June 2013. Demographic details were obtained from the ASH patient management database and the results of tests for sexually transmitted infections (STI) were obtained from the ASH pathology database.
Results: Among 1889 Indigenous patients whose HTLV-1 serostatus was known, 635 (33.6 %) were HTLV-1 Western blot positive. Only one of 77 (1.3 %) children tested was HTLV-1 infected. Thereafter, rates progressively increased with age (15-29 years, 17.3 %; 30-49 years, 36.2 %; 50-64 years, 41.7 %) reaching 48.5 % among men aged 50-64 years. In a multivariable model, increasing age (OR, 1.04; 95 % CI, 1.03-1.04), male gender (OR, 1.41; 95 % CI, 1.08-1.85), residence in the south (OR, 10.7; 95 % CI, 7.4-15.6) or west (OR, 4.4; 95 % CI, 3.1-6.3) of central Australia and previous STI (OR, 1.42; 95 % CI, 1.04-1.95) were associated with HTLV-1 infection. Infection was acquired by three of 351 adults who were tested more than once during the study period (seroconversion rate, 0.24 (95 % CI = 0.18-2.48) per 100 person-years).
Conclusions: This study confirms that HTLV-1 is highly endemic to central Australia. Although childhood infection was documented, HTLV-1 infection in adults was closely associated with increasing age, male gender and STI history. Multiple modes of transmission are therefore likely to contribute to high rates of HTLV-1 infection in the Indigenous Australian population. Future strategies to control HTLV-1 transmission in this population require careful community engagement, cultural understanding and Indigenous leadership.
Keywords: Australia; Epidemiology; HTLV-1; Indigenous; Sexually transmitted infections.
Figures
Similar articles
-
Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population.Clin Infect Dis. 2012 Jan 1;54(1):43-50. doi: 10.1093/cid/cir766. Epub 2011 Nov 17. Clin Infect Dis. 2012. PMID: 22095566
-
Human T-cell lymphotropic virus type 1 subtype C molecular variants among indigenous australians: new insights into the molecular epidemiology of HTLV-1 in Australo-Melanesia.PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2418. doi: 10.1371/journal.pntd.0002418. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24086779 Free PMC article.
-
Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population.J Clin Virol. 2016 May;78:93-8. doi: 10.1016/j.jcv.2016.03.006. Epub 2016 Mar 11. J Clin Virol. 2016. PMID: 27011343
-
HTLV-I in Australia and Oceania: long-term resident or recent immigrant?Med J Aust. 1996 Jan 15;164(2):84-6. Med J Aust. 1996. PMID: 8569578 Review.
-
Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection.Methods Mol Biol. 2017;1582:3-24. doi: 10.1007/978-1-4939-6872-5_1. Methods Mol Biol. 2017. PMID: 28357658 Review.
Cited by
-
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.Mol Pharm. 2023 Aug 7;20(8):3698-3740. doi: 10.1021/acs.molpharmaceut.2c01080. Epub 2023 Jul 24. Mol Pharm. 2023. PMID: 37486263 Free PMC article. Review.
-
Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).Pathogens. 2023 Apr 13;12(4):592. doi: 10.3390/pathogens12040592. Pathogens. 2023. PMID: 37111478 Free PMC article.
-
Prevalence of blood-borne viruses and hepatitis B vaccination status among haemodialysis patients in Central Australia.IJID Reg. 2022 Sep 27;5:111-116. doi: 10.1016/j.ijregi.2022.09.010. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36277500 Free PMC article.
-
Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.Front Immunol. 2022 Aug 16;13:949516. doi: 10.3389/fimmu.2022.949516. eCollection 2022. Front Immunol. 2022. PMID: 36052089 Free PMC article.
-
Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection.Gene. 2022 Aug 5;834:146550. doi: 10.1016/j.gene.2022.146550. Epub 2022 May 13. Gene. 2022. PMID: 35569772 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
